Radiosurgery Before Surgery for the Treatment of Brain Metastases
Key facts
- Who runs it
- Emory University
- Where
- Atlanta, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Early phase 1
- People taking part
- 26 people enrolled
- Started
- 20 Jul 2021
- Ended
- 4 Mar 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Dexamethasone
- Resection
- Stereotactic Radiosurgery
- Record updated
- 14 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Age >= 18 years
- Prior or suspected diagnosis of malignancy
- Brain metastases visible on contrasted magnetic resonance imaging (MRI) brain
- Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%)
- Life expectancy > 12 weeks as determined by the investigator
- Patients must have adequate organ function as determined by Neurosurgery to undergo surgery
- Willingness and ability of the subject to comply with scheduled visits, study procedures, and study restrictions
- Evidence of a personally signed informed consent indicating that the subject is aware of the neoplastic nature of the disease and has been informed of the procedures to be followed, the experimental nature of the therapy, alternatives, potential risks and discomforts, potential benefits, and other pertinent aspects of study participation
- Patient must have a negative pregnancy test, be actively taking oral contraceptives or have undergone a hysterectomy
Who cannot take part
- Patients on any immunosuppressive medication other than dexamethasone
- Patients who are receiving any other investigational agents or an investigational device within 21 days before administration of first dose of study drugs
- Prior whole brain radiotherapy or SRS to the same site planned for surgery
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
- Human immunodeficiency virus (HIV)-positive
- Pregnant or nursing women are excluded
Where in United States
- Emory University Hospital/Winship Cancer InstituteAtlanta, United States
About the trial
What the trial wants to find out
This early phase I trial identifies the side effects of stereotactic radiosurgery before surgery in treating patients with cancer that has spread to the brain (brain metastases). Radiation may stimulate an anti-tumor immune response. Giving stereotactic radiosurgery before surgery may reduce the risk of the cancer coming back after surgery.
The 2 groups in the trial
- Arm A (SRS, low dose dexamethasone, surgery)Treatment being tested
Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive low dose dexamethasone PO or IV for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.
Treatment: Dexamethasone, Resection, and Stereotactic Radiosurgery
- Arm B (SRS, high dose dexamethasone, surgery)Treatment being tested
Patients undergo SRS to the brain metastasis for 1-3 fractions over 1-5 days. Patients also receive high dose dexamethasone PO or IV for 2-21 days until the day of surgical resection. Patients then undergo surgical resection.
Treatment: Resection and Stereotactic Radiosurgery
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Preoperative Radiosurgery for Brain Metastases Planned for Surgical Resection: A Two Arm Pilot Study
- Publications
- Record updated
- 14 May 2026